Lang Yanfei, Fu Weiwei, Xu Wei, Ma Chao, Tian Xiuyun, Hao Chunyi, Ding Shigang
Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Beijing Key Laboratory for Helicobacter Pylori Infection and Upper Gastrointestinal Diseases, Peking University Third Hospital, Beijing, China.
Cancer Med. 2024 Dec;13(24):e70551. doi: 10.1002/cam4.70551.
The tumor immune microenvironment, including neutrophils and tertiary lymphoid structures (TLSs), is pivotal for HCC prognosis assessment. Tumor-associated neutrophils exhibit plasticity, adopting either an antitumorigenic N1 (MPO+ CD206-) or a pro-tumorigenic N2 (MPO+ CD206+) phenotype. We explored the prognostic value of neutrophil plasticity and TLS maturity in HCC in both tumor and peritumoral tissues and addressed their interaction.
A retrospective cohort of 79 HCC patients who underwent radical resection from 2015 to 2018 was analyzed, with complete clinical characteristics and survival data of more than 5 years. Multiplex immunohistochemistry identified N1/N2 neutrophils and TLS maturity. Survival differences and correlations with clinical features were assessed.
HCC patients were divided into high- and low-level groups on the basis of the N1 and N2 classifications of neutrophils, revealing a positive correlation with prognosis in tumor tissues and a negative one in peritumoral tissues. TLS maturity stages were associated with prognosis, with a higher proportion of secondary TLS (SFL-TLS) in peritumoral tissues correlating positively with survival. Further analysis of the correlation between neutrophils and TLSs revealed that most neutrophils infiltrated outside of the TLS in the peritumoral tissues of patients with HCC, and the proportions of SFL-TLSs and N1 cells in the peritumoral tissue were negatively correlated and positively correlated with survival. Both univariate and multivariate analyses revealed that the N1/N2 ratio in peritumoral tissues was an independent prognostic predictor of HCC.
The N1/N2 ratio of neutrophils and the proportion of SFL-TLS are considered important prognostic indicators that may reflect the immune microenvironment of HCC patients.
肿瘤免疫微环境,包括中性粒细胞和三级淋巴结构(TLSs),对肝癌预后评估至关重要。肿瘤相关中性粒细胞具有可塑性,可呈现抗肿瘤的N1(MPO + CD206 -)或促肿瘤的N2(MPO + CD206 +)表型。我们探讨了中性粒细胞可塑性和TLS成熟度在肝癌肿瘤组织和瘤周组织中的预后价值,并研究了它们之间的相互作用。
分析了2015年至2018年接受根治性切除的79例肝癌患者的回顾性队列,其具有完整的临床特征和超过5年的生存数据。多重免疫组化鉴定N1/N2中性粒细胞和TLS成熟度。评估生存差异以及与临床特征的相关性。
根据中性粒细胞的N1和N2分类将肝癌患者分为高水平和低水平组,结果显示肿瘤组织中与预后呈正相关,而在瘤周组织中呈负相关。TLS成熟阶段与预后相关,瘤周组织中二级TLS(SFL - TLS)比例较高与生存呈正相关。对中性粒细胞与TLS之间相关性的进一步分析表明,大多数中性粒细胞浸润在肝癌患者瘤周组织的TLS之外,瘤周组织中SFL - TLS和N1细胞的比例与生存呈负相关和正相关。单因素和多因素分析均显示,瘤周组织中的N1/N2比值是肝癌的独立预后预测指标。
中性粒细胞的N1/N2比值和SFL - TLS的比例被认为是重要的预后指标,可能反映肝癌患者的免疫微环境。